We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$369M
AUM Growth
+$83.3M
Cap. Flow
+$45.9M
Cap. Flow %
12.44%
Top 10 Hldgs %
50.86%
Holding
75
New
3
Increased
21
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$35.2M
2
ABNB icon
Airbnb
ABNB
+$5.31M
3
ADBE icon
Adobe
ADBE
+$5.09M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.95M
5
GH icon
Guardant Health
GH
+$3.52M

Top Sells

Rank Stock Value
1
MP icon
MP Materials
MP
+$13.1M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$1.02M
3
EMR icon
Emerson Electric
EMR
+$300K
4
ROK icon
Rockwell Automation
ROK
+$257K
5
CPB icon
Campbell Soup
CPB
+$226K

Sector Composition

Rank Sector Weight
1 Communication Services 14.44%
2 Healthcare 12.27%
3 Consumer Discretionary 10.84%
4 Materials 8.47%
5 Consumer Staples 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTR icon
26
Nutrien
NTR
$33.2B
$4.75M 1.29%
80,921
+80
+0.1% +$4.66K
FDX icon
27
FedEx
FDX
$72.7B
$4.68M 1.27%
19,854
-8
-0% -$1.84K
AAPL icon
28
Apple
AAPL
$4.54T
$4.17M 1.13%
16,364
– –
ALB icon
29
Albemarle
ALB
$13.9B
$4.08M 1.11%
50,312
+440
+0.9% +$33.9K
REGN icon
30
Regeneron Pharmaceuticals
REGN
$78.5B
$3.93M 1.06%
+6,981
New +$3.95M
MOS icon
31
The Mosaic Company
MOS
$7.03B
$3.8M 1.03%
109,710
+1,760
+2% +$60.6K
NKE icon
32
Nike
NKE
$61.9B
$3.45M 0.94%
49,507
+5,084
+11% +$379K
T icon
33
AT&T
T
$159B
$3.25M 0.88%
114,942
-50
-0% -$1.42K
GLW icon
34
Corning
GLW
$119B
$3.19M 0.86%
38,903
-7
-0% -$457
KO icon
35
Coca-Cola
KO
$377B
$3.09M 0.84%
46,602
-25
-0.1% -$1.72K
VXUS icon
36
Vanguard Total International Stock ETF
VXUS
$155B
$2.89M 0.78%
39,326
– –
CLX icon
37
Clorox
CLX
$11.6B
$2.76M 0.75%
22,345
– –
CPB icon
38
Campbell Soup
CPB
$6.55B
$1.8M 0.49%
57,000
-7,000
-11% -$226K
SBUX icon
39
Starbucks
SBUX
$120B
$1.67M 0.45%
19,753
– –
PSLV icon
40
Sprott Physical Silver Trust
PSLV
$12B
$1.53M 0.42%
97,637
– –
PDD icon
41
Pinduoduo
PDD
$126B
$1.41M 0.38%
10,700
– –
SLV icon
42
iShares Silver Trust
SLV
$28B
$1.28M 0.35%
30,194
+2,000
+7% +$71.8K
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.18M 0.32%
2,350
+1,700
+262% +$823K
LOW icon
44
Lowe's Companies
LOW
$117B
$1.18M 0.32%
4,689
– –
CGON icon
45
CG Oncology
CGON
$6.28B
$1.01M 0.27%
25,000
– –
MCD icon
46
McDonald's
MCD
$192B
$957K 0.26%
3,150
– –
PG icon
47
Procter & Gamble
PG
$336B
$663K 0.18%
4,316
– –
AMZN icon
48
Amazon
AMZN
$2.92T
$612K 0.17%
2,787
– –
MSFT icon
49
Microsoft
MSFT
$3.45T
$581K 0.16%
1,122
– –
WMT icon
50
Walmart Inc
WMT
$885B
$574K 0.16%
5,573
– –
1
2
3

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Sicart Associates held 75 positions worth $369M, up 29% from $286M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sicart Associates deployed $45.9M of net new capital in Q3 2025, opening 3 new positions and adding to 21 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 6,981 shares worth $3.93M.

By sector, the portfolio is most concentrated in Communication Services at 14% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was MP Materials, an estimated $13.1M trimmed.

  • Sicart Associates's largest Q3 2025 buy was Regeneron Pharmaceuticals: 6,981 shares worth $3.93M.
  • Sicart Associates added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2025, an estimated $35.2M increase.
  • Sicart Associates's biggest Q3 2025 reduction was MP Materials, cutting an estimated $13.1M.
  • Sicart Associates fully exited Emerson Electric in Q3 2025, selling an estimated $300K.
  • Sicart Associates's ten largest holdings make up 51% of its $369M portfolio in Q3 2025.
  • Sicart Associates opened 3 new positions and closed 2 in Q3 2025.
  • Sicart Associates's portfolio value rose 29% quarter-over-quarter to $369M.

Based on Sicart Associates's 13F filing for Q3 2025, filed 7 Oct 2025.